195 related articles for article (PubMed ID: 37104214)
1. Proton-Pump Inhibitors and Serum Concentrations of Uremic Toxins in Patients with Chronic Kidney Disease.
El Chamieh C; Larabi IA; Laville SM; Jacquelinet C; Combe C; Fouque D; Laville M; Frimat L; Pecoits-Filho R; Lange C; Stengel B; Alencar De Pinho N; Alvarez JC; Massy ZA; Liabeuf S;
Toxins (Basel); 2023 Apr; 15(4):. PubMed ID: 37104214
[TBL] [Abstract][Full Text] [Related]
2. Proton pump inhibitor-induced risk of chronic kidney disease is associated with increase of indoxyl sulfate synthesis via inhibition of CYP2E1 protein degradation.
Lu S; Zhao J; Chen X; Xu S; Yang X; Zhang Y; Ma Z; Jiang H; Zhou H
Chem Biol Interact; 2022 Dec; 368():110219. PubMed ID: 36243147
[TBL] [Abstract][Full Text] [Related]
3. Two rapid, accurate liquid chromatography tandem mass spectrometry methods for the quantification of seven uremic toxins: An application for describing their accumulation kinetic profile in a context of acute kidney injury.
André C; Bennis Y; Titeca-Beauport D; Caillard P; Cluet Y; Kamel S; Choukroun G; Maizel J; Liabeuf S; Bodeau S
J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Sep; 1152():122234. PubMed ID: 32615535
[TBL] [Abstract][Full Text] [Related]
4. Association between Dental Scores and Saliva Uremic Toxins.
Rigothier C; Catros S; Bénard A; Samot J; Quintin O; Combe C; Larabi I; Massy Z; Alvarez JC
Toxins (Basel); 2023 Nov; 15(11):. PubMed ID: 37999529
[TBL] [Abstract][Full Text] [Related]
5. Predictive value of protein-bound uremic toxins for heart failure in patients with chronic kidney disease.
Zwaenepoel B; De Backer T; Glorieux G; Verbeke F
ESC Heart Fail; 2024 Feb; 11(1):466-474. PubMed ID: 38041505
[TBL] [Abstract][Full Text] [Related]
6. Correlation between Saliva Levels and Serum Levels of Free Uremic Toxins in Healthy Volunteers.
Fabresse N; Larabi IA; Abe E; Lamy E; Rigothier C; Massy ZA; Alvarez JC
Toxins (Basel); 2023 Feb; 15(2):. PubMed ID: 36828466
[TBL] [Abstract][Full Text] [Related]
7. Adverse outcomes of proton pump inhibitors in patients with chronic kidney disease: The CKD-REIN cohort study.
Liabeuf S; Lambert O; Metzger M; Hamroun A; Laville M; Laville SM; Frimat L; Pecoits-Filho R; Fouque D; Massy ZA; Jacquelinet C; Stengel B;
Br J Clin Pharmacol; 2021 Jul; 87(7):2967-2976. PubMed ID: 33368448
[TBL] [Abstract][Full Text] [Related]
8. Exploring Protein Binding of Uremic Toxins in Patients with Different Stages of Chronic Kidney Disease and during Hemodialysis.
Deltombe O; Van Biesen W; Glorieux G; Massy Z; Dhondt A; Eloot S
Toxins (Basel); 2015 Sep; 7(10):3933-46. PubMed ID: 26426048
[TBL] [Abstract][Full Text] [Related]
9. Associations among total p-cresylsulfate, indoxyl sulfate and hippuric acid levels with hemodialysis quality indicators in maintenance hemodialysis patients.
Lu YC; Wu CC; Tsai IT; Hung WC; Lee TL; Hsuan CF; Yu TH; Wei CT; Chung FM; Lee YJ; Wang CP
Clin Chim Acta; 2021 May; 516():83-91. PubMed ID: 33508250
[TBL] [Abstract][Full Text] [Related]
10. Association Between Kidney Clearance of Secretory Solutes and Cardiovascular Events: The Chronic Renal Insufficiency Cohort (CRIC) Study.
Chen Y; Zelnick LR; Huber MP; Wang K; Bansal N; Hoofnagle AN; Paranji RK; Heckbert SR; Weiss NS; Go AS; Hsu CY; Feldman HI; Waikar SS; Mehta RC; Srivastava A; Seliger SL; Lash JP; Porter AC; Raj DS; Kestenbaum BR;
Am J Kidney Dis; 2021 Aug; 78(2):226-235.e1. PubMed ID: 33421453
[TBL] [Abstract][Full Text] [Related]
11. Exploring binding characteristics and the related competition of different protein-bound uremic toxins.
Deltombe O; de Loor H; Glorieux G; Dhondt A; Van Biesen W; Meijers B; Eloot S
Biochimie; 2017 Aug; 139():20-26. PubMed ID: 28528271
[TBL] [Abstract][Full Text] [Related]
12. The Effect of Sevelamer on Serum Levels of Gut-Derived Uremic Toxins: Results from In Vitro Experiments and A Multicenter, Double-Blind, Placebo-Controlled, Randomized Clinical Trial.
Bennis Y; Cluet Y; Titeca-Beauport D; El Esper N; Ureña P; Bodeau S; Combe C; Dussol B; Fouque D; Choukroun G; Liabeuf S
Toxins (Basel); 2019 May; 11(5):. PubMed ID: 31109001
[TBL] [Abstract][Full Text] [Related]
13. Proton Pump Inhibitor Use and the Risk of Chronic Kidney Disease.
Lazarus B; Chen Y; Wilson FP; Sang Y; Chang AR; Coresh J; Grams ME
JAMA Intern Med; 2016 Feb; 176(2):238-46. PubMed ID: 26752337
[TBL] [Abstract][Full Text] [Related]
14. Does p-cresylglucuronide have the same impact on mortality as other protein-bound uremic toxins?
Liabeuf S; Glorieux G; Lenglet A; Diouf M; Schepers E; Desjardins L; Choukroun G; Vanholder R; Massy ZA;
PLoS One; 2013; 8(6):e67168. PubMed ID: 23826225
[TBL] [Abstract][Full Text] [Related]
15. The Prescription of Drugs That Inhibit Organic Anion Transporters 1 or 3 Is Associated with the Plasma Accumulation of Uremic Toxins in Kidney Transplant Recipients.
André C; Mernissi T; Choukroun G; Bennis Y; Kamel S; Liabeuf S; Bodeau S
Toxins (Basel); 2021 Dec; 14(1):. PubMed ID: 35050992
[TBL] [Abstract][Full Text] [Related]
16. Accumulation of uraemic toxins is reflected only partially by estimated GFR in paediatric patients with chronic kidney disease.
Snauwaert E; Van Biesen W; Raes A; Holvoet E; Glorieux G; Van Hoeck K; Van Dyck M; Godefroid N; Vanholder R; Roels S; Walle JV; Eloot S
Pediatr Nephrol; 2018 Feb; 33(2):315-323. PubMed ID: 28939943
[TBL] [Abstract][Full Text] [Related]
17. Proton Pump Inhibitors and Risk of Acute and Chronic Kidney Disease: A Retrospective Cohort Study.
Hart E; Dunn TE; Feuerstein S; Jacobs DM
Pharmacotherapy; 2019 Apr; 39(4):443-453. PubMed ID: 30779194
[TBL] [Abstract][Full Text] [Related]
18. Protein-bound uremic toxins, inflammation and oxidative stress: a cross-sectional study in stage 3-4 chronic kidney disease.
Rossi M; Campbell KL; Johnson DW; Stanton T; Vesey DA; Coombes JS; Weston KS; Hawley CM; McWhinney BC; Ungerer JP; Isbel N
Arch Med Res; 2014 May; 45(4):309-17. PubMed ID: 24751327
[TBL] [Abstract][Full Text] [Related]
19. Gut Microbiota and Uremic Retention Solutes in Adults With Moderate CKD: A 6-Day Controlled Feeding Study.
Wiese GN; Biruete A; Stremke ER; Lindemann SR; Jannasch A; Moorthi RN; Moe SM; Swanson KS; Cross TW; Hill Gallant KM
J Ren Nutr; 2024 Jan; 34(1):26-34. PubMed ID: 37468049
[TBL] [Abstract][Full Text] [Related]
20. The Impact of Uremic Toxicity Induced Inflammatory Response on the Cardiovascular Burden in Chronic Kidney Disease.
Claro LM; Moreno-Amaral AN; Gadotti AC; Dolenga CJ; Nakao LS; Azevedo MLV; de Noronha L; Olandoski M; de Moraes TP; Stinghen AEM; Pécoits-Filho R
Toxins (Basel); 2018 Sep; 10(10):. PubMed ID: 30249039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
